Development of an miRNA signature for individual prognostic assessment in seminoma patients. Test characteristics of ctDNA stratified by primary or post-chemotherapy RPLND.

Cabozantinib improves progression-free survival (PFS) in patients with advanced extrapancreatic neuroendocrine tumors and pancreatic neuroendocrine tumors compared with placebo. Cabozantinib ...